Literature DB >> 19941396

Identification of cellular partners of Influenza A virus (H5N1) non-structural protein NS1 by yeast two-hybrid system.

S Ngamurulert1, T Limjindaporn, P Auewaraku.   

Abstract

Influenza A virus (IAV) subtype H5N1 is associated with the re-emergence of severe human influenza. The virus is highly virulent and viral non-structural protein 1 (NS1) is believed to play a crucial role in the viral pathogenesis. A screening for human proteins interacting with NS1 was performed by a yeast two-hybrid system (Y2H). Two bait plasmids that expressed DNA binding domain (BD) fused to either RNA binding domain or to effector domain of NS1 were constructed and transformed into yeast. The bait yeast was mated with a prey yeast containing human macrophage cDNA library fused to DNA activation domain. Obtained clones were interacting with interleukin-6 receptor (IL-6R), MHC class I HLA-B, cathepsin B, ubiquitin, and adenosine deaminase acting on RNA (ADAR1). These proteins play important role in the immune response, targeting for proteosomal degradation, and RNA editing. Thus, IAV H5N1 may use NS1 to manipulate these host proteins for its own benefit and in that way confer an unusual severity to the infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941396     DOI: 10.4149/av_2009_03_153

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  11 in total

Review 1.  Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase.

Authors:  Jean-François Gélinas; Guerline Clerzius; Eileen Shaw; Anne Gatignol
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

2.  Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosis.

Authors:  Ixsy A Ramirez; Lindsay J Caverly; Lindsay L Caverly; Linda M Kalikin; Adam M Goldsmith; Toby C Lewis; David T Burke; John J LiPuma; Uma S Sajjan; Marc B Hershenson
Journal:  Ann Am Thorac Soc       Date:  2014-05

3.  Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection.

Authors:  Nicholas S Heaton; Natasha Moshkina; Romain Fenouil; Thomas J Gardner; Sebastian Aguirre; Priya S Shah; Nan Zhao; Lara Manganaro; Judd F Hultquist; Justine Noel; David Sachs; Jennifer Hamilton; Paul E Leon; Amit Chawdury; Shashank Tripathi; Camilla Melegari; Laura Campisi; Rong Hai; Giorgi Metreveli; Andrea V Gamarnik; Adolfo García-Sastre; Benjamin Greenbaum; Viviana Simon; Ana Fernandez-Sesma; Nevan J Krogan; Lubbertus C F Mulder; Harm van Bakel; Domenico Tortorella; Jack Taunton; Peter Palese; Ivan Marazzi
Journal:  Immunity       Date:  2016-01-19       Impact factor: 31.745

4.  Double-stranded RNA adenosine deaminase ADAR-1-induced hypermutated genomes among inactivated seasonal influenza and live attenuated measles virus vaccines.

Authors:  Rodolphe Suspène; Vincent Petit; David Puyraimond-Zemmour; Marie-Ming Aynaud; Michel Henry; Denise Guétard; Christophe Rusniok; Simon Wain-Hobson; Jean-Pierre Vartanian
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

Review 5.  Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral.

Authors:  Charles E Samuel
Journal:  Virology       Date:  2011-01-05       Impact factor: 3.616

6.  Mutations in the M-gene segment can substantially increase replication efficiency of NS1 deletion influenza A virus in MDCK cells.

Authors:  R van Wielink; M M Harmsen; D E Martens; B P H Peeters; R H Wijffels; R J M Moormann
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

7.  The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication.

Authors:  Benoît de Chassey; Anne Aublin-Gex; Alessia Ruggieri; Laurène Meyniel-Schicklin; Fabrine Pradezynski; Nathalie Davoust; Thibault Chantier; Lionel Tafforeau; Philippe-Emmanuel Mangeot; Claire Ciancia; Laure Perrin-Cocon; Ralf Bartenschlager; Patrice André; Vincent Lotteau
Journal:  PLoS Pathog       Date:  2013-07-04       Impact factor: 6.823

Review 8.  Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs.

Authors:  R Gasparini; D Amicizia; P L Lai; N L Bragazzi; D Panatto
Journal:  J Prev Med Hyg       Date:  2014-09

9.  Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus subgroup B using SILAC coupled to LC-MS/MS.

Authors:  Diane C Munday; Julian A Hiscox; John N Barr
Journal:  Proteomics       Date:  2010-12       Impact factor: 3.984

10.  Biased mutational pattern and quasispecies hypothesis in H5N1 virus.

Authors:  Ramona Alikiiteaga Gutiérrez; Alain Viari; Bernard Godelle; Roger Frutos; Philippe Buchy
Journal:  Infect Genet Evol       Date:  2011-10-29       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.